BIOX
Income statement / Annual
Last year (2024), Bioceres Crop Solutions Corp.'s total revenue was $464.83 M,
an increase of 10.82% from the previous year.
In 2024, Bioceres Crop Solutions Corp.'s net income was $3.24 M.
See Bioceres Crop Solutions Corp.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
12/31/2015 |
Operating Revenue |
$464.83 M
|
$419.45 M
|
$328.46 M
|
$206.70 M
|
$172.35 M
|
$160.31 M
|
$133.49 M
|
$93.71 M
|
$5.10 M
|
Cost of Revenue |
$282.40 M |
$239.20 M |
$202.02 M |
$115.82 M |
$92.86 M |
$86.68 M |
$77.09 M |
$59.86 M |
$3.88 M |
Gross Profit |
$182.43 M |
$180.25 M |
$126.44 M |
$90.88 M |
$79.49 M |
$73.62 M |
$56.40 M |
$33.85 M |
$1.22 M |
Gross Profit Ratio |
0.39 |
0.43 |
0.38 |
0.44 |
0.46 |
0.46 |
0.42 |
0.36 |
0.24 |
Research and Development
Expenses |
$17.18 M
|
$15.35 M
|
$6.95 M
|
$5.62 M
|
$4.20 M
|
$3.69 M
|
$3.95 M
|
$3.98 M
|
$302,774.00
|
General & Administrative
Expenses |
$77.45 M
|
$70.23 M
|
$42.99 M
|
$29.83 M
|
$23.75 M
|
$25.98 M
|
$33.02 M
|
$25.29 M
|
$1.14 M
|
Selling & Marketing
Expenses |
$16.82 M
|
$16.71 M
|
$16.03 M
|
$7.41 M
|
$5.73 M
|
$4.86 M
|
$2.24 M
|
$2.10 M
|
$91,492.00
|
Selling, General &
Administrative Expenses |
$106.97 M
|
$86.94 M
|
$59.02 M
|
$37.24 M
|
$29.48 M
|
$30.84 M
|
$35.26 M
|
$27.39 M
|
$1.23 M
|
Other Expenses |
$12.61 M |
-$221,010.00 |
-$292,729.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$136.77 M |
$125.94 M |
$86.11 M |
$52.94 M |
$41.32 M |
$41.83 M |
$38.55 M |
$41.32 M |
$1.03 M |
Cost And Expenses |
$420.01 M |
$365.13 M |
$288.13 M |
$168.75 M |
$134.18 M |
$128.52 M |
$115.64 M |
$101.18 M |
$4.91 M |
Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$7.73 M |
$1.49 M |
$0.00 |
$14.92 M |
$689,594.00 |
Interest Expense |
$26.87 M |
$21.23 M |
$14.95 M |
$18.92 M |
$19.40 M |
$21.84 M |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$21.30 M
|
$19.39 M
|
$9.19 M
|
$6.26 M
|
$4.73 M
|
$4.83 M
|
$4.37 M
|
$4.61 M
|
$73,608.00
|
EBITDA |
$54.15 M
|
$61.09 M
|
$40.03 M
|
$37.04 M
|
$29.58 M
|
$17.29 M
|
-$12,765.00
|
$3.90 M
|
-$261,342.00
|
EBITDA Ratio |
0.12 |
0.17 |
0.15 |
0.21 |
0.31 |
0.09 |
0.14 |
0.04 |
-0.05 |
Operating Income Ratio
|
0.1
|
0.13
|
0.12
|
0.19
|
0.23
|
0.2
|
0.12
|
-0.01
|
-0.07
|
Total Other
Income/Expenses Net |
-$34.79 M
|
-$35.08 M
|
-$25.81 M
|
-$27.85 M
|
-$32.70 M
|
-$41.46 M
|
-$40.95 M
|
-$21.68 M
|
$689,823.00
|
Income Before Tax |
$10.04 M |
$19.11 M |
$14.06 M |
$10.53 M |
$6.44 M |
-$9.37 M |
-$25.24 M |
-$22.39 M |
-$503,285.00 |
Income Before Tax Ratio
|
0.02
|
0.05
|
0.04
|
0.05
|
0.04
|
-0.06
|
-0.19
|
-0.24
|
-0.1
|
Income Tax Expense |
$3.78 M |
-$1.07 M |
$17.97 M |
$14.35 M |
$2.21 M |
$6.99 M |
-$10.93 M |
$5.63 M |
$690,726.00 |
Net Income |
$3.24 M |
$18.78 M |
-$7.20 M |
-$6.87 M |
$3.36 M |
-$18.37 M |
-$11.04 M |
-$11.82 M |
-$1.19 M |
Net Income Ratio |
0.01 |
0.04 |
-0.02 |
-0.03 |
0.02 |
-0.11 |
-0.08 |
-0.13 |
-0.23 |
EPS |
0.0516 |
0.3 |
-0.17 |
-0.18 |
0.093 |
-0.6 |
-0.39 |
-0.42 |
0 |
EPS Diluted |
0.0511 |
0.3 |
-0.17 |
-0.18 |
0.0922 |
-0.6 |
-0.39 |
-0.42 |
0 |
Weighted Average Shares
Out |
$62.84 M
|
$62.15 M
|
$42.30 M
|
$39.22 M
|
$36.12 M
|
$30.48 M
|
$28.10 M
|
$28.10 M
|
$0.00
|
Weighted Average Shares
Out Diluted |
$63.49 M
|
$63.19 M
|
$42.30 M
|
$39.22 M
|
$36.42 M
|
$30.48 M
|
$28.10 M
|
$28.10 M
|
$0.00
|
Link |
|
|
|
|
|
|
|
|
|